Melanoma

SYS-MEL: Systems-Based View of Melanoma Progression: Towards Novel Diagnostic (and Therapeutic) Applications

In our Industry-Academia Partnerships and Pathways (IAPP) project, SYS-MEL, we are collectively developing molecular assays to aid in the clinical management of melanoma. » read more

 
'Target Melanoma: Molecular Dissection of Melanoma Progression: An Integrated Pan-European Approach' image

Target Melanoma: Molecular Dissection of Melanoma Progression: An Integrated Pan-European Approach

Target Melanoma: Molecular Dissection of Melanoma Progression: An Integrated Pan-European Approach A Marie Curie Industry-Academia Partnerships and Pathways funded program Malignant melanoma is one of the most aggressive and deadliest forms of cancer, characterised by early metastasis (or spreading of the disease), bad prognosis and poor survival. » read more